Other studies have demonstrated that the overexpression of ELMO1 promotes cell motility and invasion in hepatocellular carcinoma and serous ovarian cancer (Li et al., 2019; Wang et al., 2014). Here, ELMO1 is linked to ovarian serous adenocarcinoma.